Novartis

Novartis, headquartered in Basel, has emerged as a defining pharmaceuticals force in Europe. With roughly 76k employees and revenues approaching $45B, the group keeps reinforcing its position through disciplined capital allocation and a long-term industrial vision.

Recent strategic moves point to a deliberate pivot toward higher-margin segments, where pricing power and brand equity matter more than pure volume.

“Novartis is, in its category, exactly the kind of compounding regional champion the next decade of capital allocation will reward.”

Governance upgrades and a more transparent disclosure cadence are gradually narrowing the historical valuation gap with global peers.